Back to Search
Test Name REF LAB PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Orderable CPT -
OVT 123002549
Synonyms -
Result Test Name QUEST PD L1 RESULT
Laboratory QUEST LAB
Result Test Code 123924782
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 83054-7
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST COLLECTION SITE
Laboratory QUEST LAB
Result Test Code 123924779
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST COLLECTION SITE
Laboratory QUEST LAB
Result Test Code 12386001727
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST PRIMARY TUMOR SITE:
Laboratory QUEST LAB
Result Test Code 123924778
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 22035-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST PRIMARY TUMOR SITE:
Laboratory QUEST LAB
Result Test Code 12386007575
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 22035-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST PARAFFIN BLOCK NUMBER:
Laboratory QUEST LAB
Result Test Code 12386027129
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 55752-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST REPORTING PATHOLOGIST:
Laboratory QUEST LAB
Result Test Code 123924783
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 19139-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST PARAFFIN BLOCK NUMBER:
Laboratory QUEST LAB
Result Test Code 12386007405
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST ONCOLOGIST NAME:
Laboratory QUEST LAB
Result Test Code 123924780
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST ONCOLOGIST NAME:
Laboratory QUEST LAB
Result Test Code 12386014289
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature
Result Test Name QUEST INTERNAL NUMBER:
Laboratory QUEST LAB
Result Test Code 123924781
Laboratory Test Name QUEST PD L1 NON LUNG (PEMBROLIZUMAB)IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin-embedded (FFPE) tissue collected in IHC specimen transport kit Alternative Specimen(s) 5 (5 micron) unstained charged(+) slides collected in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions Tumor primary is not one of the specific types available for this FDA approved test. FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimen.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Non-Lung (Pembrolizumab) IHC - PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying patients for treatment with KEYTRUDA? (Pembrolizumab). This FDA approved test currently is applicable only to specific tumor types. For non-FDA approved test indications or sample types order 94007-PD-L1 IHC with Interpretation. For other FDA approved primary tumors please order the following: For NSCLC order 93279-PD-L1 Lung (Pembrolizumab) IHC 93359-PD-L1 Lung (Nivolumab) IHC or 94480-PD-L1 Lung (Atezolizumab) IHC; for urothelial bladder carcinoma order 94047-PD-L1 Bladder (Atezolizumab)IHC.
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature